The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
297.20
-0.70 (-0.23%)
At close: Nov 4, 2026

DSE:IBNSINA Balance Sheet

Millions BDT. Fiscal year is Jul - Jun.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
297.31314.9365.23232.23342.61
Short-Term Investments
-22.5166.79--
Cash & Short-Term Investments
297.31337.4532.02232.23342.61
Cash Growth
-11.88%-36.58%129.09%-32.22%21.82%
Accounts Receivable
189.77189.86195.8396.143.61
Other Receivables
-6.196.6911.0310.22
Receivables
189.77196.05202.51107.1353.83
Inventory
1,9721,8081,5851,1571,008
Other Current Assets
843.2503.71300.44340.44232.54
Total Current Assets
3,3032,8452,6201,8361,637
Property, Plant & Equipment
7,4334,6213,8263,1032,596
Long-Term Investments
-46.6654.1757.2256.11
Other Long-Term Assets
75.133.729.058.821.66
Total Assets
10,8107,5476,5095,0064,310

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
1,307396.18260.3282.31166.18
Accrued Expenses
-246.61249.51218.0497.59
Short-Term Debt
2,636953.681,243512.14534.29
Current Portion of Long-Term Debt
172.53119.4562.372.2170.18
Current Portion of Leases
-23.825.5422.4122.06
Current Income Taxes Payable
719.78495.25284.58212.06165.56
Other Current Liabilities
28.04241.6193.32142.368.17
Total Current Liabilities
4,8642,4772,3181,4611,124
Long-Term Debt
1,197974.71530.49330.09368.01
Long-Term Leases
--24.851.3474.75
Pension & Post-Retirement Benefits
0.510.991.191.010.73
Long-Term Deferred Tax Liabilities
93.0396.46101.18105.81117.72
Other Long-Term Liabilities
-000-0-
Total Liabilities
6,1553,5492,9761,9501,685

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
312.44312.44312.44312.44312.44
Retained Earnings
4,2253,6303,1942,7112,293
Comprehensive Income & Other
-20.51-15.54-8.61-2.27-0.69
Total Common Equity
4,5173,9273,4973,0212,604
Minority Interest
139.2470.9535.8835.0520.66
Shareholders' Equity
4,6563,9983,5333,0562,625
Total Liabilities & Equity
10,8107,5476,5095,0064,310

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
4,0062,0721,886988.191,069
Net Cash (Debt)
-3,709-1,717-1,328-723.75-695.57
Net Cash Growth
-----
Net Cash Per Share
-118.71-54.94-42.52-23.16-22.26
Filing Date Shares Outstanding
31.2431.2431.2431.2431.24
Total Common Shares Outstanding
31.2431.2431.2431.2431.24
Working Capital
-1,561368.68302.22374.96512.52
Book Value Per Share
144.56125.69111.9496.6883.36
Tangible Book Value
4,5173,9273,4973,0212,604
Tangible Book Value Per Share
144.56125.69111.9496.6883.36
Construction In Progress
-1,9321,139572.47144.25